DOC
SLIDES
Featured
Recent
Articles
Topics
Upload
Login
Sign Up
Featured
Recent
Articles
Topics
Upload
Login
Sign Up
Home
›
Search Results for "placebo risk"
Search Results for 'placebo risk'
placebo risk published presentations and documents on DocSlides.
Fludrocortisone does not reduce the risk of recurrent syncope at 12 months compared with placebo i
by delcy
syncope. Given the trend towards benefit though, i...
ASCEND Randomized placebo-controlled trial of aspirin 100 mg daily in 15,480 patients with diabetes and no baseline cardiovascular
by mitsue-stanley
ASCEND Randomized placebo-controlled trial of as...
Pravastatin in Elderly Individuals at Risk of Vascular Dise
by phoebe-click
Presented at Late Breaking Clinical Trials. AHA 2...
Pravastatin in Elderly Individuals at Risk of Vascular Dise
by min-jolicoeur
Presented at Late Breaking Clinical Trials. AHA 2...
CV safety & Outcome trials of
by aaron
Oral . Antidiabetics. Adverse CV events led the F...
Evidence Based Medicine In
by megan
Pharmacy Practice. Jarrod King, Pharm. D. . PGY1 U...
PPAR ļ§ activation Clinical
by maniakti
evidence. Evolution of clinical evidence supportin...
Impact of Rosuvastatin on Atherosclerotic Progression in People with HIV at Moderate Cardiovascular
by vivian
Janine Trevillyan. , Matthias . Cavassini. , Jan F...
Monoclonal Antibodies for Treatment of COVID
by megan
- 19 Rajesh T. Gandhi, MD Massachusetts General Ho...
ACE Primary Results Presentation
by jalin
European Association for the Study of Diabetes. Li...
EDUCATIONAL SLIDE MODULES
by dsuser1
Module D: . Evaluating CV safety and potential for...
Apixaban vs VKA and
by cheryl-pisano
Apixaban vs VKA and Aspirin vs Placebo in Patie...
1-Year outcomes of perioperative beta-blockade in patients undergoing noncardiac surgery
by mitsue-stanley
Dr. PJ Devereaux on behalf of POISE. Investigato...
Kenneth W. Mahaffey, MD,
by cheryl-pisano
on behalf of the TRACER Investigators and Committ...
The Safety and Tolerability of CSL112, a Reconstituted, Inf
by faustina-dinatale
A. poA. -I . E. vent reducin. G. in . I. schemic...
EDUCATIONAL SLIDE MODULES
by cheryl-pisano
Module D: . Evaluating CV safety and potential fo...
PREVENTING COPD EXACERBATIONS
by karlyn-bohler
Christopher Worsnop. Department of Respiratory an...
The Bangkok Tenofovir Study
by marina-yarberry
An HIV pre-exposure prophylaxis trial in Thailand...
Planning for Retirement: Depression
by marina-yarberry
Richard C. Shelton, M.D.. James G. Blakemore Rese...
Disclaimer The Canadian Cardiovascular Society (CCS) welcomes reuse of our educational slide deck f
by dsuser1
www.onlinecjc.com. ). Ā . If your reuse request qu...
PROUD: Results and participant experiences
by catherine
Presented by . Mitzy. . Gafos. , behalf of the P...
Pulmonary E mbolism Dr Al Green
by morton
MD FRCP. Acute Physician JPUH. 10 Questions to be ...
PremarinIntravenousconjugated estrogens USP for injectionSpecially
by taylor
1 WARNING: ENDOMETRIAL CANCER EstrogenAlone Therap...
Evidence Synthesis
by jalin
Number 37 Genetic Risk Assessment and BRCA Mutati...
Hereditary syndromes, genetic testing and
by Kingslayer
gynaecological. cancers. Prof.. NicolettaĀ . Col...
DOXEPIN HYDROCHLORIDE CAPSULES, USP
by roy
DXPN:R27mc 10 mg, 25 mg, 50 mg, 75 mg and 100 mg...
Effect of Exenatide Once-Weekly on Clinical Outcomes in Patients with Type 2 Diabetes Mellitus and Cardiovascular Disease: Insights from the EXSCEL Trial
by relylancome
Robert J. Mentz, M. Angelyn Bethel, Peter Merrill,...
Application of the Data:
by giovanna-bartolotta
Cardiometabolic Disease Is an Epidemic. Clinical ...
1 Role
by sherrill-nordquist
of . Candesartan. Antagonist: AT. 1. receptor i...
Aspirin for Preventing the Recurrence of Venous
by liane-varnes
Thromboembolism. N . Engl. J Med. 2012;366:1959-...
Suicide
by giovanna-bartolotta
Risk. and . Antidepressants. Background. The War...
Intake of Magnesium Sulfate In Pregnant Women May Help to R
by debby-jeon
Jillian Clinton. . . Characteristics of Cere...
1 Role
by marina-yarberry
of . Candesartan. Antagonist: AT. 1. receptor i...
Perioperative
by pasty-toler
Aspirin & . POISE-2. Neal Gerstein, MD FASE. ...
TZDās in the management of diabetes & CV disease: All
by conchita-marotz
Prof. John Betteridge, MD. University College Lon...
Protecting the heart and the kidney:
by marina-yarberry
Implications from the SHARP trial. Dr. Christina ...
Cardiovascular Disease in Women: Update on Menopausal
by briana-ranney
Hormone Therapy and Selective Estrogen Receptor M...
LDL Cholesterol Lowering with
by shoffer
Evolocumab. and Outcomes in Patients with . Perip...
Diabetic dyslipidemia : The pro-
by deborah
atherogenic. role of CETP and future use of CETP ...
The Impending D eath of Cancer:
by elina
A Herculean Task. Emerging Therapies 2016. Ruemu E...
Load More...